First day Affordable Care Act (ACA) enrollment surpassed numbers from last year; CVS will offer next-day and same-day prescription delivery in 2018; and voter confusion surrounds Ohio's drug-pricing ballot measure.
In the first few days of open enrollment for the Affordable Care Act (ACA), numbers of people enrolling in coverage have surpassed the previous year. On the first day, more than 200,000 Americans chose a plan, which is more than double the number who signed up on day 1 in 2016, reported The Washington Post. Despite the White House reducing funding for promoting the ACA, traffic to HealthCare.gov was up 33% over last year. State exchanges are reporting similar increases. For example, Colorado reported more than 4000 people logged into the exchange, far surpassing the expected 2700.
With Amazon’s potential entry hanging over the pharmacy industry, CVS has announced a new strategy to offer next-day delivery of prescription drugs in 2018. In some big cities, CVS will offer same-day service, according to The New York Times. The announcement also follows falling retail sales, including prescription sales. At this time, the delivery partner for CVS has not yet been announced.
Ads around Ohio’s Drug Price Relief Act has muddied the waters and caused confusion for voters, who will need to weigh in on the single ballot-box question next week. According to Kaiser Health News, the act is supposed to combat rising drug costs, and the issue has gotten a lot of attention. Opponents and supporters have spent $58 million and $14 million, respectively. A similar measure was rejected in California last year.
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been falling. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More